FIELD: chemistry.
SUBSTANCE: invention relates to a compound of chemical formula I, in which R1 is C1-6 alkyl and R2 and R3 each independently represent hydrogen. Invention also relates to use of the compound.
Chemical formula I
EFFECT: technical result is obtaining a new compound of chemical formula I, which is effective in treating or inhibiting human immunodeficiency virus (HIV).
3 cl, 6 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRROLOPYRIDINE DERIVATIVE AND ITS USE | 2021 |
|
RU2815649C1 |
| NEW QUINAZOLIONIC DERIVATIVES INHIBITING PI3K, AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2017 |
|
RU2702904C1 |
| IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, METHODS FOR PRODUCTION THEREOF AND USE THEREOF | 2017 |
|
RU2725147C1 |
| CONDENSED RING HETEROARYL COMPOUNDS AND USE THEREOF AS TRK INHIBITORS | 2015 |
|
RU2708674C2 |
| FLUORINE-SUBSTITUTED (3R,4R,5S)-5-GUANIDINO-4-ACYLAMINO-3-(PENTAN-3-YLOXY)CYCLOHEXENE-1-CARBOXYLIC ACIDS, ESTERS THEREOF AND METHOD OF APPLICATION | 2012 |
|
RU2489422C1 |
| NEW SALT OF TENOFOVIR DISOPROXIL | 2015 |
|
RU2660438C1 |
| NEW PYRIMIDINE DERIVATIVE SUBSTITUTED WITH DEUTERIUM AND PHARMACEUTICAL COMPOSITION CONTAINING IT | 2020 |
|
RU2811770C1 |
| NEW PYRIMIDINE DERIVATIVE WITH AN EFFECT OF INHIBITING GROWTH OF CANCER CELLS AND PHARMACEUTICAL COMPOSITION CONTAINING IT | 2018 |
|
RU2744168C1 |
| NOVEL 4-METHEXIPIROLS DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2016 |
|
RU2663895C1 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
